Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2 Propylpentanoic Acid
2. 2-propylpentanoic Acid
3. Convulsofin
4. Depakene
5. Depakine
6. Depakote
7. Dipropyl Acetate
8. Divalproex
9. Divalproex Sodium
10. Ergenyl
11. Magnesium Valproate
12. Propylisopropylacetic Acid
13. Semisodium Valproate
14. Sodium Valproate
15. Valproate
16. Valproate Calcium
17. Valproate Sodium
18. Valproic Acid
19. Valproic Acid, Sodium Salt (2:1)
20. Vupral
1. 33433-82-8
2. Valproic Acid Calcium Salt
3. Valproate Calcium
4. Calcium;2-propylpentanoate
5. 56cck4f86g
6. Valontin
7. Calcium 2-propylpentanoate
8. Calcium Dipropylacetate
9. Valproic Acid Hemi-calcium Salt
10. Calcium Bis(2-propylpentanoate)
11. Dipropylacetic Acid Calcium Salt
12. 2-propylpentanoic Acid Calcium Salt
13. Dipropylacetate De Calcium [french]
14. Dipropylacetate De Calcium
15. Einecs 251-521-7
16. Unii-56cck4f86g
17. Pentanoic Acid, 2-propyl-, Calcium Salt
18. 2-propylvaleric Acid Calcium Salt (2:1)
19. Ccris 8570
20. Convulsofin (tn)
21. Valeric Acid, 2-propyl-, Calcium Salt (2:1)
22. Schembl139237
23. Dtxsid5020237
24. Akos015915492
25. D08667
26. Valeric Acid, 2-propyl-, Calcium Salt
27. Q27261400
28. Pentanoic Acid, 2-propyl-, Calcium Salt (2:1)
Molecular Weight | 326.48 g/mol |
---|---|
Molecular Formula | C16H30CaO4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 8 |
Exact Mass | 326.1770003 g/mol |
Monoisotopic Mass | 326.1770003 g/mol |
Topological Polar Surface Area | 80.3 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 87.9 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
GABA Agents
Substances used for their pharmacological actions on GABAergic systems. GABAergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as GABA Agents.)
Antimanic Agents
Agents that are used to treat bipolar disorders or mania associated with other affective disorders. (See all compounds classified as Antimanic Agents.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
ABOUT THIS PAGE
A Valontin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Valontin, including repackagers and relabelers. The FDA regulates Valontin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Valontin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Valontin supplier is an individual or a company that provides Valontin active pharmaceutical ingredient (API) or Valontin finished formulations upon request. The Valontin suppliers may include Valontin API manufacturers, exporters, distributors and traders.
Valontin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Valontin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Valontin GMP manufacturer or Valontin GMP API supplier for your needs.
A Valontin CoA (Certificate of Analysis) is a formal document that attests to Valontin's compliance with Valontin specifications and serves as a tool for batch-level quality control.
Valontin CoA mostly includes findings from lab analyses of a specific batch. For each Valontin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Valontin may be tested according to a variety of international standards, such as European Pharmacopoeia (Valontin EP), Valontin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Valontin USP).
LOOKING FOR A SUPPLIER?